Targeting Sickle Cell Disease

Terri Booker’s body burns with pain. She’s one of the 100,000 Americans living with sickle cell disease – a blood disorder that can cause severe pain, organ failure, and even premature death. The genetic condition came about to protect against malaria. Dr. William Hobbs leads clinical development for sickle cell disease at Vertex, and they are investigating multiple approaches to address the unmet needs that patients face.

Produced by Bloomberg Media Studios and Vertex Pharmaceuticals.

Featured guests:

Terri Booker is an attorney and sickle cell advocate based in Philadelphia, Pennsylvania.

Dr. Isaac Odame  is the Haematology Section Head in the Division of Haematology/Oncology and the Medical Director of the Global Sickle Cell Disease Network at the Centre for Global Child Health at The Hospital for Sick Children.

David Altshuler is the former Chief Scientific Officer at Vertex Pharmaceuticals.

Dr. William Hobbs is the Vice President of Clinical Development, Hematology at Vertex Pharmaceuticals.

Read more about Vertex's approach to targeting sickle cell disease 
 

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.